Recent publications on Cancer

King GE, Davis RL, Baron RC, Horan JM. Participation in a worksite mammography screening program. Am J Prev Med. 8:309-13, 1992. PubMed

Daling JR, Madeleine MM, Sherman KJ, Beckmann AM, Hislop TG. Anogenital tumors associated with human papillomavirus. In: Fortner JG, Rhoads: Accomplishments in Cancer Research 1992. JP Lippincott Co, 1993:280-7. PubMed

Daling JR, Sherman KJ. Relation between human papillomavirus infection and tumors of the anogenital sites other than the cervix. In: Munoz N, Bosch FX: Proceedings of the Second International Workshop on HPV and cervical cancer. IARC 1992:223-41. PubMed

Taplin SH, Mandelson MT. Principles of cancer screening. In: Herold AH (ed). Primary Care Clinics in Office Practice. Pennsylvania, W. B. Saunders Company 1992;19:513-533. PubMed

Beckmann AM, Sherman KJ, Saran L, Weiss NS. Genital-type human papillomavirus infection is not associated with surface epithelial ovarian carcinoma. Gynecol Oncol. 1991;43(3):247-51. PubMed

Beckmann AM, Acker R, Christiansen AE, Sherman KJ. Human papillomavirus infection in women with multicentric squamous cell neoplasia. Am J Obstet Gynecol. 1991;165(5 Pt 1):1431-7. PubMed

Henderson MM, White E, Thompson RS. Cancer incidence in Seattle Women's Health Trial Participants by group and time since randomization. J Natl Cancer Inst. 1991;83(17):1260-1. PubMed

Sherman KJ, Daling JR, Chu J, Weiss NS, Ashley RL, Corey L. Genital warts, other sexually transmitted diseases, and vulvar cancer. Epidemiology. 1991;2(4):257-62. PubMed

Newcomb PA, Weiss NS, Storer BE, Scholes D, Young BE, Voigt LF. Breast self-examination in relation to the occurrence of advanced breast cancer. J Natl Cancer Inst. 1991;83(4):260-5. PubMed

Taplin SH, Barlow WE, Anderman C, Timlin D, Immanuel V, Kanvik S. Update on GHC's Breast Cancer Screening Program. GHC Medical Forum. 1991;1(5):19-27. PubMed

McEvoy JP. What's hot: prostatic specific antigen: a useful screening test? GHC Medical Forum. 1991;1(5):17-8. PubMed

Davis RL. Blindness and the incidence of breast cancer. Epidemiology. 2(6):458, November 1991. PubMed

Montano D, Taplin S. A test of an expanded theory of reasoned action to predict mammography participation. Soc Sci Med., 1991;32(6):733-741. PubMed

Henderson MM. A population-based cancer prevention research unit.  Cancer Detect Prev. 1991;15(1):17-9. PubMed

Katz SJ, Thomas DB, Hislop TG, Larson EB. Detection and time to diagnosis and treatment of breast cancer in Washington and British Columbia. Clin Res. 1991;39:143A. PubMed

Taplin SH, Anderman C, Grothaus L. Breast cancer risk and participation in mammographic screening. Abstract requested by the Clinical Digest Series. Obstetrics and Gynecology Digest. 1990;6:21-2. PubMed

Mustin H, Carter A, Sailer J, Thompson L. Screening for prostate cancer: is ultrasound the answer? HMO Pract. 1990;4(5):157-61. PubMed

Taplin SH, Thompson RS, Schnitzer F, Anderman C, Immanuel V. Revisions in the risk-based breast cancer screening program at Group Health Cooperative. Cancer. 1990;66(4):812-8. PubMed

The NCI Breast Cancer Screening Consortium. Screening mammography: a missed clinical opportunity? results of the NCI Breast Cancer Screening Consortium and National Health Interview Survey studies. JAMA. 1990;264(1):54-8. PubMed

Schumacher MC, Jick SS, Jick H, Feld AD. Cimetidine use and gastric cancer. Epidemiology. 1990;1(3):251-4. PubMed